Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
IBRX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

34.59

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

0.03

EPS Last/This Y

-0.46

EPS This/Next Y

0.9

Price

7.64

Target Price

12.75

Analyst Recom

1

Performance Q

Upside

-265.1%

Beta

0.12

Ticker: IBRX



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13IBRX7.80.280.25630224
2026-07-14IBRX7.90.290.48632547
2026-07-15IBRX7.720.290.20634762
2026-07-16IBRX7.450.290.44639554
2026-07-17IBRX7.660.280.48643002
2026-07-20IBRX7.490.260.45532770
2026-07-21IBRX8.060.260.10539586
2026-07-22IBRX7.520.260.45545131
2026-07-23IBRX7.410.271.10551489
2026-07-24IBRX7.090.270.52557672
2026-07-27IBRX70.270.33550292
2026-07-28IBRX6.970.270.27556161
2026-07-29IBRX6.840.270.21558725
2026-07-30IBRX7.440.270.12560543
2026-07-31IBRX7.20.270.31566657
2026-08-03IBRX7.170.270.50552019
2026-08-04IBRX6.970.270.70558035
2026-08-05IBRX7.290.280.09562363
2026-08-06IBRX7.310.270.37566107
2026-08-07IBRX7.630.271.18567533
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13IBRX7.8020.0527.4-0.85
2026-07-14IBRX7.8820.0513.8-0.85
2026-07-15IBRX7.7220.0520.1-0.85
2026-07-16IBRX7.4520.0523.9-0.85
2026-07-17IBRX7.6620.0510.0-0.85
2026-07-20IBRX7.4920.0521.2-0.85
2026-07-21IBRX8.0620.0499.6-0.85
2026-07-22IBRX7.5220.0530.7-0.85
2026-07-23IBRX7.4120.0519.0-0.85
2026-07-24IBRX7.0920.0525.4-0.85
2026-07-27IBRX7.0020.0518.4-0.85
2026-07-28IBRX6.9620.0516.9-0.85
2026-07-29IBRX6.8320.0520.3-0.85
2026-07-30IBRX7.4720.0496.1-0.85
2026-07-31IBRX7.1820.0524.1-0.84
2026-08-03IBRX7.1520.0516.8-0.84
2026-08-04IBRX7.1520.0516.8-0.84
2026-08-05IBRX7.2620.0506.7-0.84
2026-08-06IBRX7.3220.0514.3-0.84
2026-08-07IBRX7.640.0655.4-0.84
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13IBRX-0.142.0033.93
2026-07-14IBRX-0.142.0033.93
2026-07-15IBRX-0.142.0033.93
2026-07-16IBRX-0.142.0033.93
2026-07-17IBRX-0.142.0033.93
2026-07-20IBRX-0.142.1133.93
2026-07-21IBRX-0.142.1133.93
2026-07-22IBRX-0.112.1133.93
2026-07-23IBRX-0.112.1133.93
2026-07-24IBRX-0.112.1133.93
2026-07-27IBRX-0.111.9434.59
2026-07-28IBRX-0.111.9434.59
2026-07-29IBRX-0.111.9434.59
2026-07-30IBRX-0.111.9434.59
2026-07-31IBRX-0.111.9434.59
2026-08-03IBRX-0.111.7934.59
2026-08-04IBRX-0.111.7934.59
2026-08-06IBRX-0.111.7934.59
2026-08-07IBRX-0.111.7934.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS​

-0.08

Avg. EPS Est. Current Quarter

-0.07

Avg. EPS Est. Next Quarter

-0.05

Insider Transactions

-0.11

Institutional Transactions

1.79

Beta

0.12

Average Sales Estimate Current Quarter

58

Average Sales Estimate Next Quarter

70

Fair Value

Quality Score

71

Growth Score

50

Sentiment Score

38

Actual DrawDown %

38.6

Max Drawdown 5-Year %

-89.4

Target Price

12.75

P/E

Forward P/E

PEG

P/S

57.43

P/B

P/Free Cash Flow

EPS

-0.97

Average EPS Est. Cur. Y​

-0.84

EPS Next Y. (Est.)

0.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-703.91

Relative Volume

0.74

Return on Equity vs Sector %

67.5

Return on Equity vs Industry %

83.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

655.4
◆ IBRX Healthcare
$7.64
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
8/20
Pullback
15/25
Volume
9/15
Valuation
10/20
TP/AR
2/10
Options
7/10
RSI
52
Range 1M
34.6%
Sup Dist
6.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
18 /100
WEAK
Momentum
2/25
Growth
5/30
Estimates
3/20
Inst/Vol
3/15
Options
5/10
EPS Yr
-152.6%
52W%
53.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -45% upside
Quality
8/30
Valuation
0/30
Growth
2/25
Stability
7/10
LT Trend
2/5
Upside
-45%
Quality
71
Click a card to see score breakdown Full Analysis →
IBRX — P/E HistoricalBiotechnology
ImmunityBio, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 684
ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.
IBRX

Latest News

—
Caricamento notizie per IBRX…
stock quote shares IBRX – ImmunityBio, Inc. Stock Price stock today
news today IBRX – ImmunityBio, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch IBRX – ImmunityBio, Inc. yahoo finance google finance
stock history IBRX – ImmunityBio, Inc. invest stock market
stock prices IBRX premarket after hours
ticker IBRX fair value insiders trading